Tracker

ETF universe handoff

Opening ETF evidence benchSynchronizing prices, risk metrics, holdings coverage, and source lineage

Company context

HCA Healthcare, Inc.

NYSE:HCA

Hospital/Nursing Management · benchmarked against Health Services inside the XLV constituent company universe.

Active tabFinancial reports

Current readWeak

Last close372.62

1M return-10.66%

Open symbol page Watchlist context

OverviewVerdict, thesis map, and valuation setup.FundamentalsDrivers, trajectory, and business quality.Financial reportsStatement tables, sorting, filtering, and acceleration.Ex-ante forecastTarget price, dividend yield, and total return by horizon.FactorsCompany factor exposure, rank, and universe context.Market viewMomentum, catalysts, charts, and symbol packet.AttributionLarge-move causes, residuals, and research backlog.OwnershipSEC 13F holder flow, crowding, and manager changes.PeersPeer heatmap and closest comparables.

Tab scope

Raw financial statements

Financial reports

Source and lookbackStored financial report rows12 report snapshots; latest report Jul 15, 8:25 PM GMT+8.

Sample and caveat25 reported metrics across 4 sections.Use this tab for its stated job; heavier model packets stay on their own tabs.

Traditional statement tables

Financial reports

12 reports · latest Jul 15, 8:25 PM GMT+8

Distinct report rows12

Sections4

Metrics shown25of 28 tracked

Coverage89%

CompanyHCA Healthcare, Inc.

Overview scoring

Fundamental overview

60/100 blended · 98/100 confidence · benchmark Closest peers

Blended fundamental score: Earnings 62/100; Cash flow 62/100; Balance sheet 48/100; Valuation 73/100.

Broad comparison

Cohort scorecard

Coverage-adjusted score with thinner cohorts automatically down-weighted

Cohort scorecard: Closest peers 59/100; Hospital/Nursing Management 72/100; Health Services 62/100; XLV constituent company universe 61/100.

Selected company rank

Rank and percentile

Confidence-adjusted standing inside each cohort

Rank and percentile: Closest peers #4 of 13; Hospital/Nursing Management #2 of 2; Health Services #3 of 11; XLV constituent company universe #5 of 59.

Section scoring matrix

Earnings, cash flow, balance sheet, and valuation

Heatmap score by cohort and statement section

Section scoring matrix: Closest peers Earnings 62/100; Cash flow 60/100; Balance sheet 50/100; Valuation 68/100.

Sort byFilter metrics

Specialist report review

Quant, PM, and risk-manager reads

Deterministic review lanes from stored report metrics

Quant review

Favorable acceleration9/21

Quick ratio has the largest second-order move at -27.80%. 9 metrics are accelerating favorably and 12 are decelerating.

Fundamental PM review

Growth and cash quality2/5

EPS TTM is 29.87 with +2.72% latest change. The PM lane checks revenue, EPS, cash flow, and margin confirmation together.

Risk manager review

Risk controls need review2 watch items

Current ratio is 0.83 with -13.65% latest change. The risk lane checks leverage, liquidity, and cash-yield deterioration.

Indexed report history

Financial report trend chart

First visible report = 100

Financial report trend chart: Total revenue 75.6B; Revenue quarter 19.1B; Revenue next quarter 19.6B; Operating income TTM 12B.

Second order change

Acceleration chart

Favorable acceleration means the latest move improved versus the prior move

Acceleration chart: Total revenue -0.65%; Revenue quarter -3.91%; Operating income TTM -2.79%; Operating margin -1.12%.

PM / risk lens

Risk and quality radar

Directional score from change and acceleration

Risk and quality radar: Growth 49/100; Cash 56/100; Quality 42/100; Balance 23/100; Valuation 71/100.

Earnings

Metric trend table

10 of 10 metrics shown

Metric	Latest	Change	Acceleration	Trend	Samples
Total revenueRevenue	75.6B	+1.65%+1.2B	-0.65%-446M	improving	10
Revenue quarterRevenue	19.1B	-2.07%-404M	-3.91%-756M	decelerating	11
Revenue next quarterRevenue	19.6B	+1.50%+290.5M	Need 3 reportsNeed 3 reports	improving	2
Operating income TTMEarnings	12B	+0.07%+8M	-2.79%-324M	decelerating	11
Operating marginProfitability	+15.84%	+0.07%+0.01 pts	-1.12%-0.17 pts	decelerating	11
EPS TTMEarnings	29.87	+2.72%+0.79	+0.28%+0.10	improving	9
EPS next quarterEarnings	7.16	-3.37%-0.25	Need 3 reportsNeed 3 reports	deteriorating	2
Gross marginQuality	+15.67%	-0.97%-0.15 pts	-2.15%-0.34 pts	decelerating	11
Net marginQuality	+8.89%	-0.89%-0.08 pts	-6.08%-0.52 pts	decelerating	11
Gross-to-net conversionQuality	+56.74%	+0.08%+0.05 pts	-3.89%-2.12 pts	decelerating	11

Historical statement rows

Earnings report history

12 dated rows

Snapshot date	Total revenue	Revenue quarter	Revenue next quarter	Operating income TTM	Operating margin	EPS TTM	EPS next quarter	Gross margin	Net margin	Gross-to-net conversion
Oct 2, 2023	63.2B	16.2B	—	9.2B	+14.63%	—	—	+14.63%	+9.05%	+61.87%
Jan 2, 2024	65B	17.3B	—	9.6B	+14.82%	—	—	+14.82%	+8.07%	+54.45%
Apr 1, 2024	66.7B	17.3B	—	9.8B	+14.62%	—	—	+14.62%	+8.20%	+56.09%
Jul 1, 2024	68.3B	17.5B	—	10.2B	+14.90%	21.31	—	+14.90%	+8.40%	+56.34%
Oct 7, 2024	69.6B	17.5B	—	10.5B	+15.08%	22.28	—	+15.08%	+8.52%	+56.46%
Jan 6, 2025	70.6B	18.3B	—	10.5B	+14.94%	21.99	—	+14.94%	+8.16%	+54.61%
Apr 7, 2025	71.6B	18.3B	—	10.8B	+15.15%	22.51	—	+15.15%	+8.07%	+53.30%
Jul 7, 2025	72.7B	18.6B	—	11.1B	+15.24%	23.81	—	+15.24%	+8.21%	+53.90%
Oct 6, 2025	74.4B	19.2B	—	11.6B	+15.64%	25.88	—	+15.64%	+8.53%	+54.53%
Jan 5, 2026	75.6B	19.5B	—	12B	+15.83%	28.38	—	+15.83%	+8.97%	+56.70%
Apr 27, 2026	75.6B	19.1B	19.3B	12B	+15.84%	29.08	7.41	+15.67%	+8.89%	+56.74%
Jul 15, 2026	75.6B	—	19.6B	—	—	29.87	7.16	—	—	—